ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics. ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics. Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.
View Top Employees from ACROBiosystemsWebsite | http://www.acrobiosystems.com |
Revenue | $102.5 million |
Employees | 138 (106 on RocketReach) |
Founded | 2010 |
Address | 1 Innovation Way, Newark, Delaware 19711, US |
Phone | (800) 810-0816 |
Fax | +61 3 3279 6397 |
Technologies |
JavaScript,
HTML,
Twitter
+19 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Proprietary HEK293 expression platform, Business Services, In-house developed enzymatic and chemical biotin labeling techni |
Keywords | Recombinant Proteins, Scientific Advancement, Biopharmaceuticals, Drug Development And Manufacturing, Clinical Trials, Pharmaceuticals, Biotechnology, Health Care |
Competitors | BioLegend, Cusabio Technology LLC, LFB USA, Repligen Corporation, Sino Biological, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular ACROBiosystems employee's phone or email?
The ACROBiosystems annual revenue was $102.5 million in 2024.
Yiding Chen is the President and Chief Executive Officer of ACROBiosystems.
106 people are employed at ACROBiosystems.
ACROBiosystems is based in Newark, Delaware.
The NAICS codes for ACROBiosystems are [5417, 54171, 54, 541, 541714].
The SIC codes for ACROBiosystems are [873, 87].